Self-recognition and the role of fetal microchimerism

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 18, Issue 2, 2004, Pages 197-211

  Ando, Takao ^a   Davies, Terry F ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Fetal cell; Postpartum; Pregnancy

Indexed keywords

AMIODARONE; CD34 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA; FETAL ANTIGEN; HLA ANTIGEN; HLA DQ ANTIGEN; HLA DR3 ANTIGEN; IODINE; SEX HORMONE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; AUTOIMMUNITY; BACTERIAL INFECTION; DISEASE EXACERBATION; DNA DETERMINATION; EMOTIONAL STRESS; FETUS; GENETIC SUSCEPTIBILITY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; MICROCHIMERISM; NONHUMAN; PREGNANCY DISORDER; PUERPERIUM; RADIATION EXPOSURE; REVIEW; RISK ASSESSMENT; T LYMPHOCYTE ACTIVATION; THYROIDITIS; TISSUE INJURY;

EID: 3042665700     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2004.03.002     Document Type: Review

References (100)

1. Amino N, Mori H, Iwatani Y, et al. High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. New England Journal of Medicine 1982; 306: 849-852.
2. Tainer JA, Deal CD, Geysen HM, et al. Defining antibody-antigen recognition: towards engineered antibodies and epitopes. International Review of Immunology 1991; 7: 165-188.
3. Weiss A. Structure and function of the T cell antigen receptor. Journal of Clinical Investigation 1990; 86: 1015-1022.
4. Brown JH, Jardetzky TS, Gorga JC, et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993; 364: 33-39.
5. Schwartz RH. T cell energy. Scientific America 1993; 269: 62-63. see also pages 66-71.
6. Smith TJ, Sciaky D, Phipps RP, et al. CD40 expression in human thyroid tissue: evidence for involvement of multiple cell types in autoimmune and neoplastic diseases. Thyroid 1999; 9: 749-755.
7. Feldmann M. Regulation of HLA class II expression and its role in autoimmune disease. Ciba Foundation Symposium 1987; 129: 88-108.
8. Kawakami Y, Kuzuya N, Watanabe T, et al. Induction of experimental thyroiditis in mice by recombinant interferon gamma administration. Acta Endocrinologica (Copenhagen) 1990; 122: 41-48.
9. Shimojo N, Kohno Y, Yamaguchi K, et al. Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proceedings of National Academy of Science USA 1996; 93: 11074-11079.
10. Massa PT, Dorries R & ter Meulen V. Viral particles induce la antigen expression on astrocytes. Nature 1986; 320: 543-546.
11. Neufeld DS, Platzer M & Davies TF. Reovirus induction of MHC class II antigen in rat thyroid cells. Endocrinology 1989; 124: 543-545.
12. Khoury EL, Pereira L & Greenspan FS. Induction of HLA-DR expression on thyroid follicular cells by cytomegalovirus infection in vitro. Evidence for a dual mechanism of induction. American Journal of Pathology 1991; 138: 1209-1223.
13. Horwitz MS, Bradley LM, Harbertson J, et al. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nature Medicine 1998; 4: 781-785.
14. Barin JG, Afanasyeva M, Talor MV, Rose NR, Burek CL & Caturegli P. Thyroid-specific expression of IFN-gamma limits experimental autoimmune thyroiditis by suppressing lymphocyte activation in cervical lymph nodes. Journal of Immunology 2003; 170(11): 5523-5529.
15. Arata N, Ando T, Davies TF. By-stardes activation in autoimmune thyroiditis: studies on experimental autoimmune thyroiditis (EAT) in the green fluorescent mouse. 75th Annual Meeting of the American Thyroid Association, 2003. Palm Beach.
16. Srinivasappa J, Saegusa J, Prabhakar BS, et al. Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. Journal of Virology 1986; 57: 397-401.
17. Haspel MV, Onodera T, Prabhakar BS, et al. Virus-induced autoimmunity: monoclonal antibodies that react with endocrine tissues. Science 1983; 220: 304-306.
18. Burch HB, Nagy EV, Lukes YG, et al. Nucleotide and amino acid homology between the human thyrotropin receptor and the HIV-1 Nef protein: identification and functional analysis. Biochemical and Biophysical Research Communications 1991; 181: 498-505.
19. Villanueva R, Greenberg DA, Davies TF, et al. Sibling recurrence risk in autoimmune thyroid disease. Thyroid 2003; 13: 761-764.
20. Brix TH, Christensen K, Holm NV, et al. A population-based study of Graves' disease in Danish twins. Clinical Endocrinology (Oxford) 1998; 48: 397-400.
21. Yanagawa T, Mangklabruks A & DeGroot LJ. Strong association between HLA-DQAI*0501 and Graves' disease in a male Caucasian population. Journal of Clinical Endocrinology and Metabolism 1994; 79: 227-229.
22. Barlow AB, Wheatcroft N, Watson P, et al. Association of HLA-DQAI*0501 with Graves' disease in English Caucasian men and women. Clinical Endocrinology (Oxf) 1996; 44: 73-77.
23. Marga M, Denisova A, Sochnev A, et al. Two HLA DRB 1 alleles confer independent genetic susceptibility to Graves disease: relevance of cross-population studies. American Journal of Medical Genetics 2001; 102: 188-191.
24. Ueda H, Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-511.
25. Kim TY, Park YJ, Hwang JK, et al. A C/T polymorphism in the 5′-untranslated region of the CD40 gene is associated with Graves' disease in Koreans. Thyroid 2003; 13: 919-925.
26. Tomer Y, Concepcion E, Greenberg DA & A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 2002; 12: 1129-1135.
27. Tomer Y, Greenberg DA, Concepcion E, et al. Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. Journal of Clinical Endocrinology and Metabolism 2002; 87: 404-407.
28. Ban Y, Greenberg DA, Concepcion E, et al. Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proceedings of National Academy of Science USA 2003; 100: 15119-15124.
29. Tomer Y, Barbesino G, Greenberg DA, et al. Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. Journal of Clinical Endocrinology and Metabolism 1999; 84: 4656-4664.
30. Barbesino G, Tomer Y, Concepcion ES, et al. Linkage analysis of candidate genes in autoimmune thyroid disease. II. Selected gender-related genes and the X-chromosome. International Consortium for the Genetics of Autoimmune Thyroid Disease. Journal of Clinical Endocrinology and Metabolism 1998; 83: 3290-3295.
31. Tomer Y & Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocrine Review 2003; 24: 694-717.
32. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clinical Endocrinology (Oxford) 1995; 43: 55-68.
33. Hall R & Stanbury JB. Familial studies of autoimmune thyroiditis. Clinical and Experimental Immunology 1967; 2: 719-725.
34. Tomer Y, Greenberg DA, Barbesino G, et al. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. Journal of Clinical Endocrinology and Metabolism 2001; 86: 1687-1693.
35. Rapoport B, Alsabeh R, Aftergood D & McLachlan SM. Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease. Thyroid 2000; 10(8): 685-692.
36. Tomer Y & Davies TF. Infection, thyroid disease, and autoimmunity. Endocrine Review 1993; 14: 107-120.
37. Lidman K, Eriksson U, Norberg R, et al. Indirect immunofluorescence staining of human thyroid by antibodies occurring in Yersinia enterocolitica infections. Clinical and Experimental Immunology 1976; 23: 429-435.
38. Wenzel BE, Heesemann J, Wenzel KW, et al. Antibodies to plasmid-encoded proteins of enteropathogenic Yersinia in patients with autoimmune thyroid disease. Lancet 1988; 1: 56.
39. Carter JK & Smith RE. Rapid induction of hypothyroidism by an avian leukosis virus. Infection and Immunity 1983; 40: 795-805.
40. Ciampolillo A, Marini V, Mirakian R, et al. Retrovirus-like sequences in Graves' disease: implications for human autoimmunity. Lancet 1989; 1: 1096-1100.
41. Wick G, Trieb K, Aguzzi A, et al. Possible role of human foamy virus in Graves' disease. Intervirology 1993; 35: 101-107.
42. Lagaye S, Vexiau P, Morozov V, et al. Human spumaretrovirus-related sequences in the DNA of leukocytes from patients with Graves disease. Proceedings of National Academy of Science USA 1992; 89: 10070-10074.
43. Humphrey M, Mosca J, Baker Jr. JR, et al. Absence of retroviral sequences in Graves' disease. Lancet 1991; 337: 17-18.
44. Neumann-Haefelin D, Fleps U, Renne R, et al. Foamy viruses. Intervirology 1993; 35: 196-207.
45. Leclere J & Weryha G. Stress and auto-immune endocrine diseases. Hormone Research 1989; 31: 90-93.
46. Winsa B, Adami HO, Bergstrom R, et al. Stressful life events and Graves' disease. Lancet 1991; 338: 1475-1479.
47. Sonino N, Girelli ME, Boscaro M, et al. Life events in the pathogenesis of Graves' disease. A controlled study. Acta Endocrinologica (Copenhagen) 1993; 128: 293-296.
48. Poliak S, Mor F, Conlon P, et al. Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system. Journal of Immunology 1997; 158: 5751-5756.
49. Ansar Ahmed S, Young PR & Penhale WJ. Beneficial effect of testosterone in the treatment of chronic autoimmune thyroiditis in rats. Journal of Immunology 1986; 136: 143-147.
50. Paavonen T. Hormonal regulation of immune responses. Annals of Medicine 1994; 26: 255-258.
51. Da Silva JA. Sex hormones, glucocorticoids and autoimmunity: facts and hypotheses. Annals of Rheumatic Disease 1995; 54: 6-16.
52. Barbesino G, Tomer Y, Concepcion ES, et al. Linkage analysis of candidate genes in autoimmune thyroid disease. II. Selected gender-related genes and the X-chromosome. International Consortium for the Genetics of Autoimmune Thyroid Disease. Journal of Clinical Endocrinology Metabolism 1998; 83: 3290-3295.
53. Imrie H, Vaidya B, Perros P, et al. Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population. Journal of Clinical Endocrinology and Metabolism 2001; 86: 626-630.
54. Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA & Davies TF. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. American Journal of Human Genetics 2003; 73(4): 736-747.
55. Stewart JJ. The female X-inactivation mosaic in systemic lupus erythematosus. Immunology Today 1998; 19: 352-357.
56. Di Matola T, D'Ascoli F, Fenzi G, et al. Amiodarone induces cytochrome c release and apoptosis through an iodine-independent mechanism. Journal of Clinical Endocrinology and Metabolism 2000; 85: 4323-4330.
57. Burikhanov RB & Matsuzaki S. Excess iodine induces apoptosis in the thyroid of goitrogen-pretreated rats in vivo. Thyroid 2000; 10: 123-129.
58. Pacini F, Vorontsova T, Molinaro E, et al. Thyroid consequences of the Chernobyl nuclear accident. Acta Paediatrica Supplement 1999; 88: 23-27.
59. Vermiglio F, Castagna MG, Volnova E, et al. Post-chernobyl increased prevalence of humoral thyroid autoimmunity in children and adolescents from a moderately iodine-deficient area in Russia. Thyroid 1999; 9: 781-786.
60. Bartalena L, Pinchera A & Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocrine Review 2000; 21: 168-199.
61. Stagnaro-Green A, Roman SH, Cobin RH, et al. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. Jama 1990; 264: 1422-1425.
62. Pratt D, Novotny M, Kaberlein G, et al. Antithyroid antibodies and the association with non-organ-specific antibodies in recurrent pregnancy loss. American Journal of Obstetrics and Gynecology 1993; 168: 837-841.
63. Weetman AP. The immunology of pregnancy. Thyroid 1999; 9: 643-646.
64. Davies TF. The thyroid immunology of the postpartum period. Thyroid 1999; 9: 675-684.
65. Kung AW & Jones BM. A change from stimulatory to blocking antibody activity in Graves' disease during pregnancy. Journal of Clinical Endocrinology and Metabolism 1998; 83: 514-518.
66. Stagnaro-Green A, Roman SH, Cobin RH, et al. A prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: evidence of a T-cell etiology for postpartum thyroid dysfunction. Journal of Clinical Endocrinology and Metabolism 1992; 74: 645-653.
67. Amino N, Tada H & Hidaka Y. Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease. Thyroid 1999; 9: 705-713.
68. Jansson R, Dahlberg PA, Winsa B, et al. The postpartum period constitutes an important risk for the development of clinical Graves' disease in young women. Acta Endocrinologica (Copenhagen) 1987; 116: 321-325.
69. Nelson JL, Hughes KA, Smith AG, et al. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. New England Journal of Medicine 1993; 329: 466-471.
70. Imaizumi M, Pritsker A, Kita M, et al. Pregnancy and murine thyroiditis: thyroglobulin immunization leads to fetal loss in specific allogeneic pregnancies. Endocrinology 2001; 142: 823-829.
71. Matalon ST, Blank M, Levy Y, et al. The pathogenic role of anti-thyroglobulin antibody on pregnancy: evidence from an active immunization model in mice. Human Reproduction 2003; 18: 1094-1099.
72. Abramson J & Stagnaro-Green A. Thyroid antibodies and fetal loss: an evolving story. Thyroid 2001; 11: 57-63.
73. Imaizumi M, Pritsker A, Kita M, et al. Non-MHC driven exacerbation of experimental thyroiditis in the postpartum period. Autoimmunity 2001; 34: 95-105.
74. Triulzi DJ & Nalesnik MA. Microchimerism, GVHD, and tolerance in solid organ transplantation. Transfusion 2001; 41: 419-426.
75. Thomas MR, Williamson R, Craft I, et al. Y chromosome sequence DNA amplified from peripheral blood of women in early pregnancy. Lancet 1994; 343: 413-414.
76. Steele CD, Wapner RJ, Smith JB, et al. Prenatal diagnosis using fetal cells isolated from maternal peripheral blood: a review. Clinical Obstetrics and Gynecology 1996; 39: 801-813.
77. Bianchi DW, Zickwolf GK, Weil GJ, et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proceedings of National Academy of Science USA 1996; 93: 705-708.
78. Bianchi DW, Flint AF, Pizzimenti MF, et al. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proceedings of National Academy of Science USA 1990; 87: 3279-3283.
79. Mueller UW, Hawes CS, Wright AE, et al. Isolation of fetal trophoblast cells from peripheral blood of pregnancy women. Lancet 1990; 336: 197-200.
80. Evans PC, Lambert N, Maloney S, et al. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 1999; 93: 2007-2033.
81. Nelson JL, Furst DE, Maloney S, et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998; 351: 559-562.
82. Corpechot C, Barbu V, Chazouilleres O, et al. Fetal microchimerism in primary biliary cirrhosis. Jounal of Hepatology 2000; 33: 696-700.
83. Invernizzi P, De Andreis C, Sirchia SM, et al. Blood fetal microchimerism in primary biliary cirrhosis. Clinical and Experimetal Immunology 2000; 122: 418-422.
84. Ando T, Imaizumi M, Graves P, et al. Fetal microchimerism in human Graves' disease. Journal Clinical Endocrinology and Metabolism 2002; 87: 3315-3320.
85. Thellin O, Coumans B, Zorzi W, et al. Tolerance to the foeto-placental 'graft 12: 731-737.
86. Bonney EA & Matzinger P. The maternal immune systems's interaction with circulating fetal cells. Journal of Immunology 1997; 158: 40-47.
87. Geifman-Holtzman O, Blatman RN & Bianchi DW. Prenatal genetic diagnosis by isolation and analysis of fetal cells circulating in maternal blood. Seminars in Perinatology 1994; 18: 366-375.
88. Lo YM, Lau TK, Chan LY, et al. Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clinical Chemistry 2000; 46: 1301-1309.
89. Lo YM, Zhang J, Leung TN, et al. Rapid clearance of fetal DNA from maternal plasma. American Journal of Human Genetics 1999; 64: 218-224.
90. Jimenez DF & Tarantal AF. Quantitative analysis of male fetal DNA in maternal serum of gravid rhesus monkeys (Macaca mulatta). Pediatric Research 2003; 53: 18-23.
91. Lambert NC, Lo YM, Erickson TD, et al. Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. Blood 2002; 100: 2845-2851.
92. Imaizumi M, Pritsker A, Unger P, et al. Intrathyroidal fetal microchimerism in pregnancy and postpartum. Endocrinology 2002; 143: 247-253.
93. Cha D, Khosrotehrani K, Kim Y, et al. Cervical cancer and microchimerism. Obstetrics and Gynecology 2003; 102: 774-781.
94. Ando T & Davies TF. Clinical Review 160: Postpartum autoimmune thyroid disease: the potential role of fetal microchimerism. Journal of Clinical Endocrinology and Metabolism 2003; 88: 2965-2971.
95. Klintschar M, Schwaiger P, Mannweiler S, et al. Evidence of fetal microchimerism in Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism 2001; 86: 2494-2498.
96. Srivatsa B, Srivatsa S, Johnson KL, et al. Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. Lancet 2001; 358: 2034-2038.
97. Okabe M, Ikawa M, Kominami K, et al. 'Green mice' as a source of ubiquitous green cells. FEBS Letter 1997; 407: 313-319.
98. Scaletti C, Vultaggio A, Bonifacio S, et al. Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. Arthritis and Rheumatism 2002; 46: 445-450.
99. Abbud Filho M, Pavarino-Bertelli EC, Alvarenga MP, et al. Systemic lupus erythematosus and microchimerism in autoimmunity. Transplantation Proceedings 2002; 34: 2951-2952.
100. Johnson KL, Samura O, Nelson JL, et al. Significant fetal cell microchimerism in a nontransfused woman with hepatitis C: Evidence of long-term survival and expansion. Hepatology 2002; 36: 1295-1297.